Bloomberg Television
@markets·3.2M subscribers·95.6K videos
Merck-Moderna Vaccine Cuts Risk of Skin Cancer Returning
Posted
December 14, 2023
Views
1,975
Likes
39
Comments
15
Engagement
December 14, 2023
1,975
39
15
2.73%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
2:55Now Playing“Today is a huge day of hope for cancer patients,” says Moderna CEO Stephane Bancel as he discusses data on a personalized vaccine developed by Merck & Co. and Moderna Inc. that helped prevent the recurrence of severe skin cancer for three years
--------
Follow Bloomberg for business news & analysis, uptotheminute market data, features, profiles and more
Connect with us on...
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
